Bioventus Inc. (BVS)
10.13
-0.01 (-0.10%)
At close: Mar 03, 2025, 3:59 PM
9.65
-4.79%
After-hours: Mar 03, 2025, 07:22 PM EST
Bioventus Balance Sheet Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY15 | FY14 |
Cash & Equivalents | 36.96M | 31.81M | 43.93M | 86.84M | 64.52M | 42.77M | 4.95M | 15.77M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | 2.64M | 29.29M | 19.38M | 3.31M | 2.78M | n/a | n/a |
Other Long-Term Assets | 3.14M | -154M | 50M | 19.38M | 3.31M | 2.78M | 393K | 298K |
Receivables | 123.05M | 136.56M | 125.05M | 88.28M | 85.13M | 72.57M | 54.51M | 47.08M |
Inventory | 91.33M | 85.41M | 61.69M | 29.12M | 27.33M | 27.4M | 35.18M | 26.67M |
Other Current Assets | 16.66M | 21.06M | 32.44M | 7.55M | 6.06M | 5.62M | 4.79M | 5.71M |
Total Current Assets | 268M | 272.57M | 263.1M | 211.79M | 183.03M | 148.35M | 99.43M | 95.23M |
Property-Plant & Equipment | 49.96M | 44.95M | 40.17M | 21.84M | 19.76M | 4.76M | 9.6M | 10.43M |
Goodwill & Intangibles | 489.81M | 1.05B | 842.82M | 241.45M | 266.31M | 286.83M | 377.85M | 324.29M |
Total Long-Term Assets | 542.91M | 1.1B | 962.76M | 282.67M | 289.37M | 294.37M | 387.93M | 335.19M |
Total Assets | 810.91M | 1.37B | 1.23B | 494.47M | 472.41M | 442.72M | 487.35M | 430.42M |
Account Payables | 23.04M | 36.7M | 16.91M | 4.42M | 6.44M | 8.21M | 8.37M | 5.38M |
Deferred Revenue | n/a | n/a | 142.35M | 99.24M | 56.96M | 40.13M | 34.37M | 25.97M |
Short-Term Debt | 27.85M | 33.06M | 21.54M | 16.96M | 13.66M | 5.25M | 37.68M | 7.88M |
Other Current Liabilities | 119.86M | 231.69M | 134.26M | 98.77M | 66.36M | 49.94M | 38.98M | 37.58M |
Total Current Liabilities | 175.5M | 304.02M | 180.86M | 122.59M | 89.02M | 65.43M | 87.69M | 52.16M |
Long-Term Debt | 367M | 399.37M | 354.68M | 187.49M | 202.49M | 189.63M | 158.83M | 163.1M |
Other Long-Term Liabilities | 46.08M | 257.05M | 23.01M | 36.87M | 6.16M | 5.38M | 39.72M | 28.35M |
Total Long-Term Liabilities | 414.3M | 728.3M | 511.21M | 227.72M | 237.78M | 232.03M | 207.32M | 200.78M |
Total Liabilities | 589.79M | 1.03B | 692.07M | 350.31M | 326.79M | 297.46M | 295.01M | 252.93M |
Total Debt | 394.85M | 418.07M | 357.68M | 188.38M | 197.97M | 194.83M | 188.51M | 170.98M |
Common Stock | 79K | 78K | 75K | 285.17M | 285.15M | 285.15M | 113.37M | 113.4M |
Retained Earnings | -321.54M | -165.31M | -6.6M | -144.54M | -141.7M | -139.82M | -91.84M | -56.49M |
Comprehensive Income | 794K | -110K | 179K | 1.61M | -465K | -65K | -650K | 14K |
Shareholders Equity | 173.59M | 316.58M | 458.92M | 142.24M | 142.98M | 145.27M | 192.34M | 177.49M |
Total Investments | -1.21M | 2.64M | 29.29M | 19.38M | 3.31M | 2.78M | n/a | n/a |